Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/jama/dermoscopy-and-overdiagnosis-of-melanoma-in-situ-PDE2JQ7A0F
References (15)
-
L Thomas, S Puig
Dermoscopy, digital dermoscopy and other diagnostic tools in the early detection of melanoma and follow-up of high-risk skin cancer patients [published online July 5, 2017] -
JP Lott, DM Boudreau, RL Barnhill (2017)
Population-based analysis of histologically confirmed melanocytic proliferations using natural language processing [published online November 1, 2017] -
A Lallas, C Longo, M Manfredini
Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ [published online February 21, 2018] -
H. Soyer, J. Smolle, H. Kerl, H. Stettner (1987)
EARLY DIAGNOSIS OF MALIGNANT MELANOMA BY SURFACE MICROSCOPYThe Lancet, 330
-
M. Luttrell, R. Hofmann-Wellenhof, R. Fink‐Puches, H. Soyer (2011)
The AC Rule for melanoma: a simpler tool for the wider community.Journal of the American Academy of Dermatology, 65 6
-
A. Steiner, H. Pehamberger, K. Wolff (1987)
In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.Journal of the American Academy of Dermatology, 17 4
-
J. Elmore, R. Barnhill, D. Elder, G. Longton, M. Pepe, L. Reisch, P. Carney, L. Titus, H. Nelson, T. Onega, A. Tosteson, M. Weinstock, S. Knezevich, M. Piepkorn (2017)
Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility studyThe BMJ, 357
-
Jose Neila, H. Soyer (2011)
Key points in dermoscopy for diagnosis of melanomas, including difficult to diagnose melanomas, on the trunk and extremitiesThe Journal of Dermatology, 38
-
H. Soyer, J. Smolle, S. Hödl, H. Pachernegg, H. Kerl (1989)
Surface Microscopy: A New Approach to the Diagnosis of Cutaneous Pigmented TumorsThe American Journal of Dermatopathology, 11
-
S. Mocellin, D. Nitti (2011)
Cutaneous melanoma in situ: translational evidence from a large population-based study.The oncologist, 16 6
-
C. Wassberg, M. Thörn, J. Yuen, T. Hakulinen, U. Ringborg (1999)
Cancer risk in patients with earlier diagnosis of cutaneous melanoma In situInternational Journal of Cancer, 83
-
B. Smithers, Jeff Dunn, H. Soyer (2017)
Whither melanoma in Australia?Medical Journal of Australia, 207
-
H. Pehamberger, Andreas Steiner, Klaus Wolff (1987)
In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.Journal of the American Academy of Dermatology, 17 4
-
J. Rhee, Wilma Bergman, N. Kukutsch (2010)
The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective studyBritish Journal of Dermatology, 162
-
J. Banky, J. Kelly, D. English, Josephine Yeatman, J. Dowling (2005)
Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.Archives of dermatology, 141 8
- Publisher
- American Medical Association
- Copyright
- Copyright 2018 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6068
- eISSN
- 2168-6084
- DOI
- 10.1001/jamadermatol.2017.6448
- Publisher site
- See Article on Publisher Site
Abstract
Opinion Editorial Published Online: February 14, 2018. 2. Weenig RH, Davis MDP, Dahl PR, Su WPD. Skin a retrospective cohort study. J Invest Dermatol. doi:10.1001/jamadermatol.2017.5979 ulcers misdiagnosed as pyoderma gangrenosum. 2012;132(9):2166-2170. N Engl J Med. 2002;347(18):1412-1418. Conflict of Interest Disclosures: Dr Kaffenberger 6. Ahronowitz I, Harp J, Shinkai K. Etiology and has performed studies in pyoderma gangrenosum 3. Maverakis E, Ma C, Shinkai K, et al. Diagnostic management of pyoderma gangrenosum: for Xoma, Xbiotech, and Eli Lilly Co, and also has criteria of ulcerative pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012; study relationships with Biogen and Celgene. No a Delphi consensus of international experts 13(3):191-211. other disclosures are reported. [published online February 14, 2018]. JAMA Dermatol. 7. Su WP, Davis MD, Weenig RH, Powell FC, Perry doi:10.1001/jamadermatol.2017.5980 HO. Pyoderma gangrenosum: clinicopathologic REFERENCES 4. Ashchyan HJ, Butler DC, Nelson CA, et al. correlation and proposed diagnostic criteria. Int J The association of age with clinical presentation Dermatol. 2004;43(11):790-800. 1. Ormerod AD, Thomas KS, Craig FE, et al; UK and comorbidities of pyoderma gangrenosum Dermatology Clinical Trials Network’s STOP GAP 8. Binus AM, Qureshi AA, Li VW, Winterfield LS. [published online February 14, 2018]. JAMA Dermatol. Team. Comparison
Journal
JAMA Dermatology – American Medical Association
Published: Apr 21, 2018